Nitroxide Antioxidant Modulation of Apoptosis Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively address dysregulation in the apoptotic pathway, leading to various diseases such as cancers, autoimmune diseases, and neurodegenerative disorders, as they do not adequately manage increased or decreased levels of apoptosis, which are associated with gene expression alterations in tissues like skin, immune, pancreatic, and neuronal tissues.
Innovation Solution
Administering an effective amount of a nitroxide antioxidant, specifically 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to reduce the expression level of genes associated with the apoptosis pathway, including Bak1, Pdcd5, Casp2, Tradd, Tp53inp1, Casp3, and Casp12, in targeted tissues to mitigate disease progression and prevent apoptosis-related conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods are used to treat apoptosis-related diseases, then treatment is provided, but the methods fail to effectively address dysregulation in the apoptotic pathway
Solution Approach 1:
The patent applies parameter changes by using a nitroxide antioxidant to modify the expression levels of apoptosis-related genes. This changes the biochemical parameters of the apoptotic pathway, enabling effective treatment of diseases caused by dysregulated apoptosis while maintaining the ability to address various gene expression alterations across different tissue types.
2Reliability
If nitroxide antioxidant is administered to reduce gene expression levels, then excessive apoptosis is counteracted, but the need for precise dosage control arises
Solution Approach 1:
The patent implements feedback control through specified dosage ranges (0.01-300 mg/kg, preferably 0.1-250 mg/kg, more preferably 1-200 mg/kg, and most preferably 2-150 mg/kg or 5-125 mg/kg or 7-100 mg/kg or 10-75 mg/kg or 15-30 mg/kg). This feedback mechanism ensures that the nitroxide antioxidant dosage is adjusted to achieve the desired reduction in apoptosis-related gene expression while preventing over-treatment or under-treatment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nitroxide antioxidant effectively reduces gene expression levels, thereby counteracting excessive apoptosis, preventing disease progression, and enhancing immune response and reducing stress-induced apoptosis, offering therapeutic benefits for conditions like Alzheimer's, autoimmune diseases, and immune system dysfunctions.
Implementation Method 1
administering to the individual an effective amount of a nitroxide antioxidant to reduce the level of expression of the gene associated with the apoptosis pathway
Data Source
AI summary
Disclosed herein are methods for treating a human subject having a disease associated with an increased level of apoptosis using a nitroxide. Further disclosed are methods for treating a human subject in need of a reduced expression level of a gene associated with the apoptosis pathway using a nitroxide.